Hereditary pheochromocytoma-paraganglioma
Autozomálně dominantní
A group of syndromes (PPGL types 1-7, TMEM127- and MAX-related) in which variants in SDHB, SDHD, SDHC, SDHA, SDHAF2, MAX or TMEM127 raise the risk of pheochromocytoma and paraganglioma.
Co se diagnózou změní
Regular blood or urine metanephrine testing and periodic whole-body MRI help find tumours early, before they cause blood-pressure crises; relatives can be offered testing.
Známé také jako
familial pheochromocytoma-paraganglioma; hereditary paraganglioma-pheochromocytoma syndrome; SDHx-related paraganglioma-pheochromocytoma
Zahrnuje 9 příbuzných podtypů ↓Skrýt podtypy ↑
- MAX-related tumor predisposition
- pheochromocytoma/paraganglioma syndrome 1
- pheochromocytoma/paraganglioma syndrome 2
- pheochromocytoma/paraganglioma syndrome 3
- pheochromocytoma/paraganglioma syndrome 4
- pheochromocytoma/paraganglioma syndrome 5
- pheochromocytoma/paraganglioma syndrome 6
- pheochromocytoma/paraganglioma syndrome 7
- TMEM127-related tumor predisposition
